NIH-funded research NIH-funded research

A new self-testing method for early HIV detection using CRISPR technology

Official title: A rapid CRISPR-based self-testing platform for early detection of HIV

Funded at University of Florida · NIH-11013398 · Data updated 2026-11-12

This study is working on a quick and easy way for people to test themselves for HIV at home using advanced CRISPR technology, so they can get results in about 30 minutes and take action sooner if needed.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startJanuary 19, 2024
Project endDecember 31, 2026
Funding year2025
Award (this year)$409,335
NIH project number5R61AI181016-02
Project IDNIH-11013398 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of HIV infection or those who may have been exposed to the virus.

Less likely to help

Patients who are already diagnosed with HIV or those who do not have risk factors for HIV infection may not benefit from this research.

What this research studies

This research focuses on developing a rapid and automated self-testing platform that utilizes CRISPR technology for the early detection of HIV. By leveraging engineered CRISPR/Cas systems, the platform aims to identify HIV RNA quickly and accurately, allowing individuals to test themselves without the need for extensive laboratory procedures. The method is designed to provide results in about 30 minutes, significantly improving the chances of early intervention and reducing the risk of transmission. The approach is based on innovative techniques that enhance the sensitivity and specificity of the tests.

Why it matters

Potential benefit: If successful, this research could lead to a highly accessible and efficient method for early HIV detection, potentially saving lives and reducing transmission rates.

How similar studies have gone: Other research has shown promising results with CRISPR-based diagnostic methods, indicating that this approach could be effective for HIV detection as well.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Jain, Piyush K — University of Florida
  • Study coordinator: Jain, Piyush K

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.